Chartwell Investment Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $10.7M | Buy |
68,900
+2,591
| +4% | +$387K | 0.37% | 76 |
|
|
2024
Q2 | $9.08M | Sell |
66,309
-400
| -0.6% | -$54.8K | 0.32% | 102 |
|
|
2024
Q1 | $8.88M | Buy |
66,709
+529
| +0.8% | +$68.6K | 0.31% | 109 |
|
|
2023
Q4 | $9.12M | Sell |
66,180
-3,810
| -5% | -$501K | 0.32% | 116 |
|
|
2023
Q3 | $8.53M | Sell |
69,990
-1,739
| -2% | -$232K | 0.33% | 100 |
|
|
2023
Q2 | $10.1M | Buy |
71,729
+1,935
| +3% | +$267K | 0.37% | 87 |
|
|
2023
Q1 | $9.88M | Buy |
69,794
+2,076
| +3% | +$297K | 0.38% | 86 |
|
|
2022
Q4 | $10.6M | Sell |
67,718
-17,276
| -20% | -$2.48M | 0.42% | 78 |
|
|
2022
Q3 | $10.4M | Buy |
84,994
+4,295
| +5% | +$566K | 0.44% | 65 |
|
|
2022
Q2 | $10.7M | Sell |
80,699
-24,437
| -23% | -$3.33M | 0.43% | 66 |
|
|
2022
Q1 | $14.4M | Sell |
105,136
-4,673
| -4% | -$651K | 0.48% | 56 |
|
|
2021
Q4 | $19M | Sell |
109,809
-2,057
| -2% | -$313K | 0.55% | 44 |
|
|
2021
Q3 | $16.3M | Sell |
111,866
-10,024
| -8% | -$1.47M | 0.51% | 55 |
|
|
2021
Q2 | $16.1M | Sell |
121,890
-9,751
| -7% | -$1.28M | 0.47% | 70 |
|
|
2021
Q1 | $16.9M | Sell |
131,641
-28,590
| -18% | -$3.52M | 0.51% | 63 |
|
|
2020
Q4 | $19.1M | Sell |
160,231
-9,460
| -6% | -$1.15M | 0.61% | 37 |
|
|
2020
Q3 | $19.4M | Buy |
169,691
+24,134
| +17% | +$2.85M | 0.71% | 25 |
|
|
2020
Q2 | $16.6M | Buy |
145,557
+2,916
| +2% | +$309K | 0.64% | 28 |
|
|
2020
Q1 | $11.5M | Sell |
142,641
-17,245
| -11% | -$1.79M | 0.54% | 51 |
|
|
2019
Q4 | $17.1M | Sell |
159,886
-6,404
| -4% | -$668K | 0.56% | 38 |
|
|
2019
Q3 | $17.8M | Sell |
166,290
-5,571
| -3% | -$572K | 0.6% | 29 |
|
|
2019
Q2 | $17.5M | Sell |
171,861
-2,604
| -1% | -$250K | 0.57% | 30 |
|
|
2019
Q1 | $15.7M | Buy |
174,465
+128,018
| +276% | +$11.1M | 0.51% | 55 |
|
|
2018
Q4 | $3.87M | Buy |
46,447
+7,655
| +20% | +$718K | 0.14% | 225 |
|
|
2018
Q3 | $4.19M | Buy |
38,792
+2,520
| +7% | +$276K | 0.12% | 247 |
|
|
2018
Q2 | $3.99M | Buy |
36,272
+15,297
| +73% | +$1.59M | 0.12% | 236 |
|
|
2018
Q1 | $2.1M | Buy |
20,975
+7,500
| +56% | +$768K | 0.07% | 286 |
|
|
2017
Q4 | $1.33M | Buy |
+13,475
| New | +$1.28M | 0.05% | 368 |
|
|
2017
Q3 | – | Sell |
-4,814
| Closed | -$535K | – | 419 |
|
|
2017
Q2 | $535K | Hold |
4,814
| – | – | 0.02% | 392 |
|
|
2017
Q1 | $473K | Hold |
4,814
| – | – | 0.02% | 390 |
|
|
2016
Q4 | $442K | Sell |
4,814
-83,000
| -95% | -$7.15M | 0.02% | 405 |
|
|
2016
Q3 | $7.43M | Sell |
87,814
-58,910
| -40% | -$4.95M | 0.13% | 207 |
|
|
2016
Q2 | $11.9M | Buy |
+146,724
| New | +$11.2M | 0.21% | 146 |
|
Other funds holding DGX
DSA
Chartwell Investment Partners's DGX Position: Q3 2024 in Review
Chartwell Investment Partners increased its Quest Diagnostics (DGX) stake by 3.9% in Q3 2024, buying an estimated $387K and bringing the position to 68,900 shares worth $10.7M. The position accounts for 0.37% of the portfolio, ranked #76.
Chartwell Investment Partners first reported a position in DGX in Q2 2016 and has held it in 33 quarters since. The position peaked at $19.4M in Q3 2020. 846 funds tracked by Wall St. Rank hold DGX as of Q3 2024.
- Chartwell Investment Partners held 68,900 shares of Quest Diagnostics worth $10.7M as of Q3 2024.
- Chartwell Investment Partners bought 2,591 Quest Diagnostics shares in Q3 2024, an estimated $387K.
- Quest Diagnostics made up 0.37% of Chartwell Investment Partners's portfolio in Q3 2024, its #76 holding.
- Chartwell Investment Partners first reported a position in Quest Diagnostics in Q2 2016 and has held it in 33 quarters since.
- Chartwell Investment Partners's Quest Diagnostics position peaked at $19.4M in Q3 2020.
- 846 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.
Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.